The Case for Reform
Stronger policy action can protect patients and restore integrity to the U.S. pharmaceutical supply chain, ensuring that every individual has access to safe and effective medicines.
Policy Pillars
ASEM is purpose-built and solutions-oriented, focusing on three key tenets:
Combating Counterfeit Drugs and Illegal Mass Compounding
The Problem
Mass-compounded products are being sold without the safeguards that make medicines trustworthy. Patients have no way of knowing what is in their product, or whether it is medicine at all.
The Solution
ASEM supports stronger FDA enforcement against mass compounders operating outside federal compounding law and clearer rules for the telehealth platforms and distribution channels that bring these products to market.
Strengthening the Integrity of the U.S. Pharmaceutical Supply Chain to Fight Counterfeit Drugs
The Problem
The U.S. pharmaceutical supply chain is built on verified standards, accountable sources, and rules that apply to every medicine reaching patients. Bad actors undermine that guarantee.
The Solution
ASEM supports stronger ingredient oversight, supplier vetting, import accountability, and manufacturing standards for every product that reaches patients.
Holding Mass Compounders and Platforms Accountable
The Problem
Patients are being targeted with misleading claims, unclear sourcing, and products that can blur the line between legitimate pharmacy practice and mass compounding.
The Solution
ASEM supports transparency and accountability for mass compounders, advertisers, prescribers, and platforms whose products and claims affect patient safety.